Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt

Indian Journal of Dermatology

Volumn 56, Issue 3, 2011, Pages 272-277

  Settin, Ahmad A ^a,b,d   Hassan, Hanaa A ^c   El Baz, Rizk A ^b   Hassan, Tahia A ^c  

^a QASSIM UNIVERSITY   (Saudi Arabia)

^b Genetics Unit   (Egypt)

^c Mansoura University   (Egypt)

^d MANSOURA UNIVERSITY   (Egypt)

Author keywords

Cytokines; gene polymorphism; psoriasis

Indexed keywords

DNA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; EGYPT; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MALE; POLYMERASE CHAIN REACTION; PSORIASIS;

EID: 79960234773     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.82479     Document Type: Article

References (38)

1. Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 2004;3:121-8. (Pubitemid 38832741)
2. Sabat R, Philipp S, Hflich C, Kreutzer S, Wallace E, Asadullah K, et al. Immunopathogenesis of psoriasis. Exp Dermatol 2007;16:779-98. (Pubitemid 47377643)
3. Chiarini A, Dal Pra I, Pacchiana R, Zumiani G, Zanoni M, Armato U. Comano's (Trentino) thermal water interferes with interleukin-6 production and secretion and with cytokeratin-16 expression by cultured human psoriatic keratinocytes: Further potential mechanisms of its anti-psoriatic action. Int J Mol Med 2006;18:1073-9.
4. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76. (Pubitemid 28467565)
5. Tripp CS, Wolf SF, Unanue ER. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 1993;90:3725-9. (Pubitemid 23111440)
6. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765. (Pubitemid 32368050)
7. Kimball AB, Kawamura T, Tejura K, Boss C, Hancox AR, Vogel JC, et al. Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo-controlled trial using recombinant human interleukin 10. Arch Dermatol 2002;138:1341-6.
8. Yu L, Yang MS, Zhao J, Shi YY, Zhao XZ, Yang JD, et al. An association between polymorphisms of the interleukin-10 gene promoter and schizophrenia in the Chinese population. Schizophr Res 2004;71:179-83. (Pubitemid 39209487)
9. Ravindran JS, Owen P, Lagan A, Lewis J, Korendowych E, Welsh K, et al. Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis. Rheumatology (Oxford) 2004;43:22-6. (Pubitemid 38088363)
10. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993;91:403-4. (Pubitemid 23177503)
11. Haider AS, Cohen J, Fei J, Zaba LC, Cardinale I, Toyoko K, et al. Insights into gene modulation by therapeutic TNF and IFNgamma antibodies: TNF regulates IFNgamma production by T cells and TNF-regulated genes linked to psoriasis transcriptome. J Invest Dermatol 2008;128:655-66. (Pubitemid 351252666)
12. Wastowski IJ, Peres NT, Simes RT, Castelli EC, Simes AL, Martinez-Rossi NM, et al. Identification of a novel 120 bp allele at the TNFd microsatellite locus. Tissue Antigens 2006;67:318-20.
13. Hajeer AH, Hutchinson IV. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol 2001;62:1191-9. (Pubitemid 33032271)
14. Gottlieb AB, Chaudhari U, Baker DG, Perate M, Dooley LT. The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): A comparison. J Drugs Dermatol 2003;2:260-6.
15. Sargen K, Demaine AG, Kingsnorth AN. Cytokine gene polymorphisms in acute pancreatitis. JOP 2000;1:24-35. (Pubitemid 38963911)
16. Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999;94:3941-6.
17. Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001;98:1594-600.
18. Wilkinson RJ, Patel P, Llewelyn M, Hirsch CS, Pasvol G, Snounou G, et al. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med 1999;189:1863-74.
19. Burden AD, Javed S, Bailey M. Genetics of psoriasis: Paternal inheritance and a locus on chromosome 6p. J Invest Dermatol 1998;110:958-60. (Pubitemid 28237704)
20. Guenther LC, Ortonne JP. Pathophysiology of psoriasis: Science behind therapy. J Cutan Med Surg 2002;6:2-7.
21. Mehlis SL, Gordon KB. The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol 2003;49:S44-50. (Pubitemid 36951246)
22. Turner DM, Williams DM, Sankaran D. An investigation of polymorphism in the interleukin-10 gene. Eur J Immunogenet 1997;24:1-8.
23. Elkayam O, Yaron I, Shirazi I. Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatol Int 2000;19:101-6.
24. Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005;2005:273-9. (Pubitemid 41577417)
25. Creaven PJ, Stoll HL. Response to tumour necrosis factor in two cases of psoriasis. J Am Acad Dermatol 1991;24:735-41.
26. Takematsu H, Ozawa H, Yoshimura T, Hara M, Sakakibara A, Oyama J, et al. Systemic TNF administration in psoriatic patients: A promising therapeutic modality for severe psoriasis. Br J Dermatol 1991;124:209-10.
27. Nedoszytko B, Szczerkowska-Dobosz A, Zabotna M, Gle J, Rebaa K, Roszkiewicz J. Associations of promoter region polymorphisms in the tumour necrosis factor-gene and early-onset psoriasis vulgaris in a northern polish population. Br J Dermatol 2007;157:165-72.
28. Reich K, Westphal G, Schulz T. Combined analysis of polymorphisms of the tumor necrosis factor-a and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol 1999;113:214-34.
29. Arias AI, Giles B, Eiermann TH, Sterry W, Pandey JP. Tumor necrosis factor-alpha gene polymorphism in psoriasis. Exp Clin Immunogenet 1997;14:118-40.
30. Craven N, Jackson C, Kirby B. Cytokine gene polymorphis in psoriasis. Br J Dermatol 2001;144:849-902.
31. Al-Heresh AM, Proctor J, Jones SM, Dixey J, Cox B, Welsh K, et al. Tumour necrosis factor-alpha polymorphism and the HLA-CwFNx010602 allele in psoriatic arthritis. Rheumatology (Oxford) 2002;41:525-30. (Pubitemid 34567182)
32. Mallon E, Bunce M, Savoie H, Rowe A, Newson R, Gotch F, et al. HLA-C and guttate psoriasis. Br J Dermatol 2000;143:1177-82. (Pubitemid 32052752)
33. Kingo K, Koks S, Silm H, Vasar E. IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes Immun 2003;4:455-61.
34. Hhler T, Kruger A, Schneider PM, Schopf RE, Knop J, Rittner C, et al. A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 1997;109:562-5. (Pubitemid 27433602)
35. Chang YT, Chou CT, Yu CW, Lin MW, Shiao YM, Chen CC, et al. Cytokine gene polymorphisms in Chinese patients with psoriasis. Br J Dermatol 2007;156:899-905. (Pubitemid 46642859)
36. Clay FE, Cork MJ, Tarlow JK. Interleukin-l receptor antagonist gene polymorphism association with lichcn sclcrosus. Hum Genet 1994;94:407-10. (Pubitemid 24297728)
37. Mansfield JC, Holdcn H, Tarlow JK. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-l receptor antagonist. Gastroenterol 1994;43:33-42.
38. Peddle L, Butt C, Snelgrove T, Rahman P. Interleukin (IL) 1alpha, IL1beta, IL receptor antagonist, and IL10 polymorphisms in psoriatic arthritis. Ann Rheum Dis 2005;64:1093-4. (Pubitemid 40909534)